Case number 1:21-cv-00315
Merck Sharp & Dohme LLC v. Zydus Worldwide DMCC et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 9, 2022 | 67 | STIPULATION of Dismissal Pursuant to Rule 41(a)(2), by Merck Sharp & Dohme LLC. (Joyce, Alexandra) Modified on 12/9/2022 (nms). (Entered: 12/09/2022) (2) |
| Dec 9, 2022 | 68 | SO ORDERED Granting (D.I. 687 in 19-md-2902-RGA; D.I. 67 in 21-cv-315-RGA) Stipulation of Dismissal Pursuant to Rule 41(a)(2). Signed by Judge Richard G. Andrews on 12/9/2022. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00315-RGA(nms) (Entered: 12/09/2022) (2) |
| Dec 9, 2022 | 69 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (Attachments: # 1 Order)(nms) (Entered: 12/09/2022) (Main Document) (1) |
| Dec 9, 2022 | 69 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (Attachments: # 1 Order)(nms) (Entered: 12/09/2022) (Order) (2) |
| Sep 19, 2022 | 66 | SO ORDERED Granting (D.I. 65 in 21-cv-315-RGA; D.I. 683 in 19-md-2902-RGA) STIPULATION and [Proposed] Order Regarding Pretrial Activities. Signed by Judge Richard G. Andrews on 9/19/2022. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00315-RGA(nms) (Entered: 09/19/2022) (3) |
| Sep 16, 2022 | 65 | STIPULATION and [Proposed] Order Regarding Pretrial Activities by Merck Sharp & Dohme LLC. (Joyce, Alexandra) (Entered: 09/16/2022) (3) |
| Sep 2, 2022 | 64 | ORAL ORDER: Due to a scheduling conflict the Bench Trial scheduled to start on 10/31/2022, is CANCELED. The Pretrial Conference scheduled for 10/14/2022, is also CANCELED. The two (2) day Bench Trial is now reset to start 1/9/2023, at 8:30 AM in Courtroom 6A. A Pretrial Conference is rescheduled for 12/19/2022, at 2:00 PM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 9/2/2022. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00315-RGA(nms) (Entered: 09/02/2022) (0) |
| Aug 31, 2022 | 62 | STIPULATION and [Proposed] Order by Merck Sharp & Dohme LLC. (Joyce, Alexandra) (Entered: 08/31/2022) (2) |
| Aug 31, 2022 | 63 | SO ORDERED Granting (D.I. 62 in 21-cv-315-RGA; D.I. 680 in 19-md-2902-RGA) Stipulation and Proposed Order. Signed by Judge Richard G. Andrews on 8/31/2022. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00315-RGA(nms) (Entered: 08/31/2022) (2) |
| Aug 23, 2022 | 61 | ORDER Granting (D.I. 678 in 19-md-2902-RGA; D.I. 60 in 21-cv-315-RGA) Unopposed Motion to Change Name of Defendant Cadila Healthcare Limited to Zydus Lifesciences Limited. Signed by Judge Richard G. Andrews on 8/23/2022. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00315-RGA(nms) (Entered: 08/23/2022) (2) |
| Aug 22, 2022 | 60 | Unopposed Motion to Change Name of Defendant Cadila Healthcare Limited to Zydus Lifesciences Limited - filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Attachments: # 1 Proposed Order)(Phillips, John) Modified on 8/22/2022 (nms). (Entered: 08/22/2022) (Main Document) (2) |
| Aug 22, 2022 | 60 | Unopposed Motion to Change Name of Defendant Cadila Healthcare Limited to Zydus Lifesciences Limited - filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Attachments: # 1 Proposed Order)(Phillips, John) Modified on 8/22/2022 (nms). (Entered: 08/22/2022) (Proposed Order) (2) |
| Aug 11, 2022 | 59 | NOTICE of Depositions by Merck Sharp & Dohme LLC (Joyce, Alexandra) (Entered: 08/11/2022) (2) |
| Aug 8, 2022 | 58 | NOTICE OF SERVICE of (1) Expert Reply Report of Adam J. Matzger, Ph.D. Regarding Zydus's Infringement of U.S. Patent No. 7,326,708 and (2) Expert Reply Report of David Macmillan, Ph.D. Regarding Zydus's Infringement of U.S. Patent No. 7,326,708 filed by Merck Sharp & Dohme LLC.(Joyce, Alexandra) (Entered: 08/08/2022) (2) |
| Jul 5, 2022 | 57 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of [CONFIDENTIAL] Responsive Expert Report of Dr. John F. Hartwig, Ph.D. on Non-Infringement of Claims 21 and 22 of the '708 Patent and [CONFIDENTIAL] Rebuttal Expert Report of Dr. Bart Kahr, Ph.D. Regarding Non-Infringement of U.S. Patent No. 7,326,708 filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) |
| Jun 21, 2022 | 56 | Order (2) Docket Text: ORDER Granting (D.I. 55 in 21-cv-315-RGA; D.I. 8 in 22-cv-444-RGA; D.I. 670 in 19-md-2902-RGA) Unopposed Motion to Substitute Plaintiff and Amend Case Caption. Signed by Judge Richard G. Andrews on 6/21/2022. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00315-RGA, 1:22-cv-00444-RGA(nms) |
| Jun 7, 2022 | 55 | Main Document (3) Docket Text: UNOPPOSED Motion to Substitute Plaintiff and Amend Case Caption - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) 7.1.1. Certification, # (2) Proposed Order)(Silver, Daniel) Modified on 6/7/2022 (nms). |
| Jun 7, 2022 | 55 | Rule 7.1.1. Certification (1) |
| Jun 7, 2022 | 55 | Text of Proposed Order (2) |
| May 17, 2022 | 54 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Expert Report of Adam J. Matzger, Ph.D. Regarding Zydus's Infringement of U.S. Patent No. 7,326,708; (2) Expert Report of David Macmillan, Ph.D. Regarding Zydus's Infringement of U.S. Patent No. 7,326,708; (3) Expert Report of Mohan Rao, Ph.D. filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| May 13, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 668 in 19-md-2902-RGA; D.I. 53 in 21-cv-315-RGA) STIPULATION and Proposed Order to Extend Time to serve opening expert reports to May 16, 2022. Signed by Judge Richard G. Andrews on 5/13/2022. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00315-RGA(nms) |
| May 13, 2022 | 53 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME the parties' deadline to serve opening expert reports to May 16, 2022 - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) |
| Apr 29, 2022 | 52 | Notice of Change of Address (2) Docket Text: NOTICE of Change of Address by Alexandra M. Joyce (Joyce, Alexandra) |
| Apr 4, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. ยง 652(b). (Taylor, Daniel) |
| Apr 4, 2022 | 51 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited's Objections and Responses to Merck Sharp & Dohme Corp.'s Second Set of Requests for Production (Nos. 74-77) and Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited's [CONFIDENTIAL] Objections and Responses to Merck Sharp & Dohme Corp.'s Third Set of Interrogatories (Nos. 11-13) filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) |
| Mar 25, 2022 | 50 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiff Merck Sharp & Dohme Corp.'s Responses and Objections to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.'s Second Set of Requests for Admission to Plaintiff (Nos. 7-15) and (2) Plaintiff Merck Sharp & Dohme Corp.'s Responses and Objections to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.'s Second Set of Interrogatories (No. 3) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Mar 23, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 49 in 21-cv-315-RGA; D.I. 662 in 19-md-2902-RGA) STIPULATION and Proposed Order to Extend Time for certain discovery deadlines. Signed by Judge Richard G. Andrews on 3/23/2022. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00315-RGA(nms) |
| Mar 23, 2022 | 49 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 3/23/2022 (nms). |
| Mar 16, 2022 | 48 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's [CONFIDENTIAL] Objections and Responses to Plaintiff's Notice of Deposition of Defendant Zydus Under Federal Rule of Civil Procedure 30(b)(6) filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) |
| Mar 3, 2022 | 47 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's [CONFIDENTIAL] Objections and Responses to Merck Sharp & Dohme Corp.'s First Set of Requests for Admission (Nos. 1-14) and Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's [CONFIDENTIAL] Objections and Responses to Merck Sharp & Dohme Corp.'s Second Set of Interrogatories (Nos. 8-10) filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) |
| Mar 1, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jonathan B. Turpin for Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. and Zydus Worldwide DMCC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:21-cv-00315-RGA, 1:19-md-02902-RGA(mal) |
| Feb 25, 2022 | 46 | Notice (Other) (2) Docket Text: NOTICE of Depositions by Merck Sharp & Dohme Corp. (Joyce, Alexandra) |
| Feb 24, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Timothy F. Peterson for Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. and Zydus Worldwide DMCC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00315-RGA(mal) |
| Feb 23, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Leah M. Brackensick for Cadila Healthcare Ltd.,Zydus Pharmaceuticals (USA) Inc.,and Zydus Worldwide DMCC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) |
| Feb 23, 2022 | 45 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's Second Set of Interrogatories to Plaintiff (No. 3) and Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's Second Set of Requests for Admission to Plaintiff (Nos. 7-15) filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) |
| Feb 22, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (657 in 19-md-2902-RGA; 44 in 21-cv-315-RGA) MOTION for Pro Hac Vice Appearance of Attorney Jonathan B. Turpin, Timothy F. Peterson and Lean M. Brackensick, filed by Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Ltd.. Signed by Judge Richard G. Andrews on 2/22/2022. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00315-RGA(nms) |
| Feb 22, 2022 | 43 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiff Merck Sharp & Dohme Corp.'s Responses and Objections to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.'s First Set of Requests for Admission to Plaintiff (Nos. 1-6) and (2) Plaintiff Merck Sharp & Dohme Corp.'s Responses and Objections to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.'s First Set of Interrogatories (Nos. 1-2) filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Feb 22, 2022 | 44 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jonathan B. Turpin, Timothy F. Peterson and Lean M. Brackensick - filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Attachments: # (1) Certification of Jonathan B. Turpin, # (2) Certification of Timothy F. Peterson, # (3) Certification of Leah M. Brackensick)(Bilson, David) |
| Feb 22, 2022 | 44 | Certification of Jonathan B. Turpin (1) |
| Feb 22, 2022 | 44 | Certification of Timothy F. Peterson (1) |
| Feb 22, 2022 | 44 | Certification of Leah M. Brackensick (1) |
| Feb 18, 2022 | 42 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Second Set of Requests for Production from Plaintiff Merck Sharp & Dohme Corp. to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd., (2) Third Set of Interrogatories from Plaintiff Merck Sharp & Dohme Corp. to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd., and (3) Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Feb 11, 2022 | 41 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Christopher J. Cassella as co-counsel. Reason for request: No Longer with Firm. (Bilson, David) |
| Feb 1, 2022 | 40 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) First Set of Requests for Admission from Plaintiff Merck Sharp & Dohme Corp. to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd., and (2) Second Set of Interrogatories from Plaintiff Merck Sharp & Dohme Corp. to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd. filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Jan 28, 2022 | 39 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Supplemental Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Jan 21, 2022 | 38 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's First Set of Interrogatories to Plaintiff (Nos. 1-2) and Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's First Set of Requests for Admission to Plaintiff (Nos. 1-6) filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) |
| Jan 13, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: IT IS ORDERED THAT as a result of the teleconference on 1/13/2022, at present I will not initiate any further contact regarding ADR/mediation unless requested by Judge Andrews or by counsel for the parties, either jointly or separately. Ordered by Judge Mary Pat Thynge on 1/13/2022. (Taylor, Daniel) |
| Sep 30, 2021 | 37 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's [CONFIDENTIAL] Objections and Responses to Merck Sharp & Dohme Corp.'s First Set of Interrogatories (Nos. 1-7) and Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's [CONFIDENTIAL] Objections and Responses to Merck Sharp & Dohme Corp.'s First Set of Requests for Production (Nos. 1-73) filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) |
| Sep 24, 2021 | 36 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Responses and Objections To Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.'s First Set of Requests for the Production of Documents and Things (Nos. 1-13) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Sep 8, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (185 in 19-cv-319-RGA; 73 in 20-cv-815-RGA; 12 in 21-cv-824-RGA; 48 in 20-cv-1496-RGA; 156 in 19-cv-314-RGA; 572 in 19-md-2902-RGA; 104 in 20-cv-949-RGA; 6 in 21-cv-1172-RGA; 91 in 20-cv-847-RGA; 114 in 20-cv-749-RGA; 35 in 21-cv-315-RGA; 109 in 20-cv-1099-RGA; 167 in 19-cv-312-RGA; 8 in 21-cv-1173-RGA; 177 in 19-cv-313-RGA) MOTION for Pro Hac Vice Appearance of Attorney David M. Krinsky, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 9/8/2021. Associated Cases: 1:19-cv-00312-RGA et al.(nms) |
| Sep 8, 2021 | 35 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David M. Krinsky - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) Certification for David M. Krinsky)(Silver, Daniel) |
| Sep 8, 2021 | 35 | Certification for David M. Krinsky (1) |
| Aug 26, 2021 | 34 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's First Set of Requests for Production to Plaintiff (Nos. 1-13) filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) |
| Aug 17, 2021 | 33 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) First Set of Requests for Production from Plaintiff Merck Sharp & Dohme Corp. to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd. and (2) First Set of Interrogatories from Plaintiff Merck Sharp & Dohme Corp. to Defendants Zydus Worldwide DMCC, Zydus Pharmaceutical (USA) Inc. and Cadila Healthcare Ltd. filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Aug 11, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Vanessa O. Omoroghomwan for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Aug 10, 2021 | 32 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Jun 30, 2021 | N/A | Order Setting Mediation Conferences (0) Docket Text: ORAL ORDER Setting Mediation Conferences: A Telephone Conference is set for 1/13/2022 at 10:30 AM before Judge Mary Pat Thynge to discuss case status and interest in mediation. Counsel for Defendants to initiate the call to chambers. Ordered by Judge Mary Pat Thynge on 6/30/2021. (Taylor, Daniel) |
| Jun 24, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (75 in 20-cv-847-RGA; 36 in 20-cv-1496-RGA; 96 in 20-cv-749-RGA; 166 in 19-cv-319-RGA; 78 in 20-cv-949-RGA; 82 in 20-cv-1099-RGA; 144 in 19-cv-314-RGA; 163 in 19-cv-313-RGA; 30 in 21-cv-315-RGA; 189 in 19-cv-1489-RGA; 10 in 21-cv-824-RGA; 155 in 19-cv-312-RGA; 61 in 20-cv-815-RGA) MOTION for Pro Hac Vice Appearance of Attorney Vanessa O. Omoroghomwan, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 6/24/2021. Associated Cases: 1:19-cv-00312-RGA et al.(nms) |
| Jun 24, 2021 | 30 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Vanessa O. Omoroghomwan - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) Certification for Vanessa O. Omoroghomwan)(Silver, Daniel) |
| Jun 24, 2021 | 30 | Certification for Vanessa O. Omoroghomwan (1) |
| Jun 14, 2021 | 29 | Order Setting Mediation Conferences (4) Docket Text: ORDER Setting Mediation Conferences: A Telephone Conference is set for 6/29/2021 at 10:30 AM before Judge Mary Pat Thynge. Counsel for plaintiff to initiate the call to chambers. Signed by Judge Mary Pat Thynge on 6/14/2021. Associated Cases: 1:21-cv-00315-RGA, 1:19-md-02902-RGA(Taylor, Daniel) |
| Jun 11, 2021 | 27 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's [CONFIDENTIAL] Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) |
| Jun 11, 2021 | 28 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Disclosures Pursuant to Paragraphs 3 and 4 of the Delaware Default Standard for Discovery filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Jun 1, 2021 | 25 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's [CONFIDENTIAL] Federal Rule of Civil Procedure 26(a)(1) Initial Disclosures filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) |
| Jun 1, 2021 | 26 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| May 12, 2021 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:21-cv-00315-RGA, 1:19-md-02902-RGA(Taylor, Daniel) |
| May 12, 2021 | 23 | Scheduling Order (8) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 9/10/2021. Amended Pleadings due by 9/10/2021. Fact Discovery completed by 3/25/2022. A Pretrial Conference is set for 10/14/2022, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 10/31/2022, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 5/12/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00315-RGA(nms) |
| May 12, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Rule 16(b) Conference scheduled for 5/13/2021, is CANCELED. Ordered by Judge Richard G. Andrews on 5/12/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-00315-RGA(nms) |
| May 11, 2021 | 21 | Proposed Order (8) Docket Text: PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 5/12/2021 (nms). |
| May 11, 2021 | 22 | Main Document (1) Docket Text: Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. regarding IPR Decision. (Attachments: # (1) IPR Decision)(Silver, Daniel) |
| May 11, 2021 | 22 | IPR Decision (77) |
| Apr 29, 2021 | 20 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 5/13/2021, at 11:00 AM before Judge Richard G. Andrews (see order for further details). Signed by Judge Richard G. Andrews on 4/29/2021. Associated Cases: 1:21-cv-00315-RGA, 1:19-md-02902-RGA(nms) |
| Apr 20, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The answer (D.I. 11), and disclosure statements (D.I. 12, 13, and 14) have been removed from the docket. This case is part of an MDL and therefore requires reference made in the caption to the MDL as well as filing therein. Defendants shall refile the documents accordingly (nms) |
| Apr 20, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michael J. Gaertner, David B. Abramowitz for Cadila Healthcare Ltd.,for Zydus Pharmaceuticals (USA) Inc.,for Zydus Worldwide DMCC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 21-cv-00315-RGA, 19-md-02902-RGA (myr) |
| Apr 20, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Christopher J. Cassella,Carolyn A. Blessing for Cadila Healthcare Ltd.,for Zydus Pharmaceuticals (USA) Inc.,for Zydus Worldwide DMCC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 21-cv-00315-RGA, 19-md-02902-RGA (myr). |
| Apr 20, 2021 | 16 | Answer to Complaint (14) Docket Text: ANSWER to [1] Complaint, and Affirmative Defenses, by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Phillips, John) Modified on 4/21/2021 (nms). |
| Apr 20, 2021 | 17 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Cadila Healthcare Ltd.. (Phillips, John) |
| Apr 20, 2021 | 18 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cadila Healthcare Limited for Zydus Worldwide DMCC, Zydus Worldwide DMCC filed by Zydus Worldwide DMCC. (Phillips, John) |
| Apr 20, 2021 | 19 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cadila Healthcare Limited for Zydus Pharmaceuticals (USA) Inc., Zydus Pharmaceuticals (USA) Inc. filed by Zydus Pharmaceuticals (USA) Inc.. (Phillips, John) |
| Apr 19, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The motion filed at D.I. 15 has been removed from the docket. This case is part of an MDL and therefore requires reference made in the caption to the MDL as well as filing therein. Defendants shall refile the document accordingly. (nms) |
| Apr 19, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 15 in 21-cv-315-RGA; D.I. 459 in 19-md-2902-RGA) MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, David B. Abramowitz, Carolyn A. Blessing and Christopher J. Cassella, filed by Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Ltd.. Signed by Judge Richard G. Andrews on 4/19/2021. Associated Cases: 1:21-cv-00315-RGA, 1:19-md-02902-RGA(nms) |
| Apr 19, 2021 | 15 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, David B. Abramowitz, Carolyn A. Blessing and Christopher J. Cassella - filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Attachments: # (1) Certification of Michael J. Gaertner, # (2) Certification of David B. Abramowitz, # (3) Certification of Carolyn A. Blessing, # (4) Certification of Christopher J. Casella)(Bilson, David) |
| Apr 19, 2021 | 15 | Certification of Michael J. Gaertner (1) |
| Apr 19, 2021 | 15 | Certification of David B. Abramowitz (1) |
| Apr 19, 2021 | 15 | Certification of Carolyn A. Blessing (1) |
| Apr 19, 2021 | 15 | Certification of Christopher J. Casella (1) |
| Mar 19, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The stipulation and proposed order filed at D.I. 6 has been removed from the docket. This case is part of an MDL and therefore requires reference made in the caption to the MDL as well as filing therein. Plaintiff shall refile the document accordingly. (nms) |
| Mar 19, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The declaration filed at D.I. 6 has been removed per the filers request. An amended version will be refiled. (nms) |
| Mar 19, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (7 in 21-cv-315-RGA; 426 in 19-md-2902-RGA) Stipulation and Proposed Order Governing Service of Process and Response Time to Complaint (*Reset Answer Deadline: Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Cadila Healthcare Ltd. answers due by 4/19/2021). Signed by Judge Richard G. Andrews on 3/19/2021. Associated Cases: 1:21-cv-00315-RGA, 1:19-md-02902-RGA(nms) |
| Mar 19, 2021 | 7 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order Governing Service of Process and Response Time to Complaint by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) |
| Mar 19, 2021 | 8 | Declaration (2) Docket Text: DECLARATION of Service made on Defendant Zydus Worldwide DMCC on March 19, 2021, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 3/19/2021 (nms). |
| Mar 19, 2021 | 9 | Declaration (2) Docket Text: DECLARATION of Service made on Defendant Zydus Pharmaceuticals (USA) Inc. on March 19, 2021, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 3/19/2021 (nms). |
| Mar 19, 2021 | 10 | Declaration (2) Docket Text: DECLARATION of Service made on Defendant Cadila Healthcare Ltd. on March 19, 2021, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 3/19/2021 (nms). |
| Mar 3, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Mar 2, 2021 | 5 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (mal) |
| Mar 1, 2021 | 1 | Main Document (11) Docket Text: COMPLAINT filed against Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3554691.) - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(mal) |
| Mar 1, 2021 | 1 | Exhibit A (18) |
| Mar 1, 2021 | 1 | Civil Cover Sheet (2) |
| Mar 1, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Mar 1, 2021 | 3 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (mal) |
| Mar 1, 2021 | 4 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp.. (mal) |
| Mar 1, 2021 | 1 | Complaint* (1) |
